Medibank share price halted after hackers claim to have taken customer data

Medibank shares have been halted after hackers made contact…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Medibank shares have been halted on Wednesday
  • This follows news that hackers claim to have taken customer data from the private health insurance giant
  • Medibank previously stated that it didn't believe customer data was removed from its systems

The Medibank Private Ltd (ASX: MPL) share price will be one to watch carefully in the coming days.

This follows the release of an update on its cybersecurity incident after the market close today.

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.

Image source: Getty Images

Why is the Medibank share price on watch?

Last week, Medibank revealed that it detected unusual activity on its network.

After taking immediate steps to contain the incident and engage specialised cyber security firms, the company stated that it didn't believe any customer data had been removed.

The company then went on to say that as a health company providing health insurance and health services, it holds a range of necessary personal information of customers. In light of this, it stressed that the protection of customers' data security is its highest priority.

Unfortunately, it may have failed with its highest priority, with the company no longer sure that customer data wasn't removed from its systems.

What's happened?

This afternoon, management revealed that it has received messages from a group that wishes to negotiate with the company regarding their alleged removal of customer data.

Medibank is treating the matter seriously and working urgently to establish if the claim is true.

As a result, the company has suspended its shares and they will remain that way until the matter is resolved.

Medibank's CEO, David Koczkar, commented:

I apologise and understand this latest distressing update will concern our customers. We have always said that we will prioritise responding to this matter as transparently as possible. "Our team has been working around the clock since we first discovered the unusual activity on our systems, and we will not stop doing that now. We will continue to take decisive action to protect Medibank customers, our people and other stakeholders.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Why this ASX healthcare stock is a top rebound candidate with big upside 

This could be a perfect buy-low candidate.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

2 ASX healthcare stocks tipped to return 34% to 63%

These companies could be poised for much bigger things.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
ASX Share Market News

Are Pro Medicus shares now too cheap to ignore?

The discount looks tempting, but slowing growth could expose valuation risks.

Read more »

Two ASX share investors sharing a secret.
Healthcare Shares

Cochlear shares are quietly rebounding: Is a bigger rally coming?

After a 58% plunge, Cochlear doesn’t need perfection to surprise investors.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

This ASX biotech is tipped to more than double in value

Encouraging trial results have the analysts excited.

Read more »

person climbing mountain
Healthcare Shares

CSL share price forecast: How high could it climb in the next year?

CSL shares could roar back, but investors need more than hope.

Read more »

Two CEOs shaking hands on a deal.
Healthcare Shares

Integral Diagnostics: FY26 results and new CFO appointment

Integral Diagnostics delivered double-digit profit growth and appointed a new CFO.

Read more »

Woman looking at stock market numbers.
Healthcare Shares

CSL shares are rising: 3 things investors need to watch

CSL’s FY26 result could reveal whether the turnaround has finally begun.

Read more »